LN-758276
Tofacitinib Impurity 6 , 98% , 1640972-35-5
Update time: 2023-04-23
PRODUCT Properties
| Melting point: | >80°C (dec.) |
| Boiling point: | 583.2±50.0 °C(Predicted) |
| Density | 1.239±0.06 g/cm3(Predicted) |
| storage temp. | -20°C Freezer |
| solubility | DMSO (Slightly), Methanol (Slightly) |
| pka | 6.04±0.60(Predicted) |
| form | Solid |
| color | Pale Yellow to Yellow |
| InChI | InChI=1S/C16H22N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h10-11,13H,3-5,7-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1 |
| InChIKey | PEURVXMHTIUQCG-YPMHNXCESA-N |
| SMILES | N([C@@H]1[C@@H](CCN(C1)C(=O)CC#N)C)(C1N=CN=C2NCCC=12)C |
Description and Uses
5,6-Dihydro CP-690550 is an impurity of CP-690550 (C781350), a pyrrolo[2,3-d]pyrimidine derivative, as Janus kinase inhibitor for treatment of rheumatoid arthritis.




![4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine](https://img.chemicalbook.com/CAS/GIF/479633-63-1.gif)

